Maven Securities’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-51,200
Closed -$2.03M 160
2018
Q2
$2.03M Buy
51,200
+13,956
+37% +$554K 1.13% 23
2018
Q1
$1.03M Buy
+37,244
New +$1.03M 0.54% 31